Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Maar et al
We Would Love a Review
The net effect on ipamorelin efficacy is unpredictable
Important Safety Information Do not use AOD-9604 if you: Have a known allergy to growth hormone fragments or any component of the formulation Have been diagnosed with active cancer or have a history of malignancy (use only under medical supervision) Are pregnant or breastfeeding (safety data is lacking) Have severe uncontrolled diabetes or metabolic disorders without medical supervision Common side effects may include: Injection site reactions, mild headaches, temporary fatigue, or slight dizziness during initial use
Weight Loss and Body Composition: In human clinical trials involving 300 participants, those treated with AOD 9604 showed a significant reduction in body weight compared to the placebo group
Several patents are pending, and there are serious offers from European companies to set up joint ventures
